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ARH GAP35 encoding p190A RhoGAP is a cancer-associated gene with a mutation spectrum suggestive of a tumor-suppressor 
function. In this study, we demonstrate that loss of heterozygosity for ARH GAP35 occurs in human tumors. We sought 
to identify tumor-suppressor capacities for p190A RhoGAP (p190A) and its paralog p190B in epithelial cells. We reveal an 
essential role for p190A and p190B to promote contact inhibition of cell proliferation (CIP), a function that relies on RhoGAP 
activity. Unbiased mRNA sequencing analyses establish that p190A and p190B modulate expression of genes associated with 
the Hippo pathway. Accordingly, we determine that p190A and p190B induce CIP by repressing YAP–TEAD-regulated gene 
transcription through activation of LATS kinases and inhibition of the Rho–ROCK pathway. Finally, we demonstrate that 
loss of a single p190 paralog is sufficient to elicit nuclear translocation of YAP and perturb CIP in epithelial cells cultured in 
Matrigel. Collectively, our data reveal a novel mechanism consistent with a tumor-suppressor function for ARH GAP35.
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Introduction
Two recent studies mapping the landscape of somatic muta-
tions in human cancer identified ARH GAP35 as a major cancer 
gene (Kandoth et al., 2013; Lawrence et al., 2014). These studies 
demonstrated that ARH GAP35 is mutated in >2% of all tumors 
and thus ranks among the top ∼30 most significantly mutated 
genes in human cancer. This discovery was surprising because 
ARH GAP35 was the only gene with such high frequency of 
mutations that was not included in the Cancer Gene Census at 
that time. The mutation rate of ARH GAP35 is particularly high 
in uterine corpus endometrioid carcinoma, and the gene is also 
frequently mutated in squamous cell carcinoma and adenocar-
cinoma of the lung, head and neck cancer, and renal cell carci-
noma (Kandoth et al., 2013; Lawrence et al., 2014). In addition, 
ARH GAP35 is located in a region of chromosome 19 that is focally 
deleted in numerous carcinomas (Zack et al., 2013).
ARH GAP35 encodes p190A RhoGAP (p190A), a major 
GTPase-activating protein (GAP) for Rho family proteins 
(Settleman et al., 1992). p190A exhibits 50% sequence identity 
and the same overall structure as p190B RhoGAP (p190B), which 
is encoded by ARH GAP5 (Burbelo et al., 1995). Both p190A and 
p190B are widely coexpressed, and each is essential for normal 
mouse development and tissue homeostasis (Brouns et al., 2000; 
Sordella et al., 2002). p190A and p190B provide spatial and tem-
poral control of Rho activity in response to extracellular signal-
ing (Burbelo et al., 1995; Nakahara et al., 1998; Wildenberg et al., 
2006). In this capacity, p190A and p190B exert profound effects 
on the actin cytoskeleton and cellular processes directly depen-
dent on actin polymerization. In addition, p190A and p190B have 
been shown to regulate transcriptional responses through TFII-I 
and CREB, respectively (Sordella et al., 2002; Jiang et al., 2005).
Cancer genome sequencing data support a tumor-suppressor 
role for ARH GAP35 (Kandoth et al., 2013; Lawrence et al., 2014). 
However, cellular functions of p190A consistent with such a role 
have not been determined. p190A plays pivotal roles in prolifer-
ative and motile capacities of mammalian cells, but the effects 
are not consistent with a tumor-suppressor role. Inhibition of 
p190A function by knockdown or overexpression of GAP-defi-
cient p190A inhibits cell spreading and protrusion, resulting in 
loss of cell polarity and perturbation of cell migration (Arthur 
and Burridge, 2001). A recent publication by Binamé et al. (2016) 
confirms that p190A is required for directional cell motility and 
that certain p190A mutations found in human cancer perturb 
directional cell motility. However, loss of directional motility 
is not a hallmark of cancer (Hanahan and Weinberg, 2011). A 
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role for p190A in cytokinesis has also been established (Su et al., 
2003). Overexpression of p190A perturbs cytokinesis, result-
ing in the emergence of multinucleate cells, and loss of p190A 
might therefore seem advantageous to cancerous cells. However, 
endogenous levels of p190A do not affect cytokinesis (Su et al., 
2009). Moreover, depletion of p190A inhibits entry into the cell 
cycle, thereby perturbing cell proliferation (Su et al., 2009). Col-
lectively, the published effects on proliferative and motile capac-
ities associated with loss of p190A function are not consistent 
with a tumor-suppressor role.
In contrast, we demonstrate in this study that p190A promotes 
contact inhibition of cell proliferation (CIP). Loss of CIP represents 
one of the earliest appreciated hallmarks of cancer (Hanahan and 
Weinberg, 2011). This effect of p190A is shared with p190B. Next, 
using an unbiased approach, we show that p190A and p190B sup-
press the transcriptional activity of YAP, an effector of the Hippo 
pathway and an established modulator of CIP (Zeng and Hong, 
2008; McClatchey and Yap, 2012; Gumbiner and Kim, 2014). We 
show that p190A and p190B signal to prevent translocation of 
YAP from the cytosol to the nucleus. Furthermore, we establish 
that p190A and p190B repress YAP-mediated gene transcription 
by activating large tumor suppressor (LATS) kinases as well as by 
inhibiting Rho–ROCK signaling. Finally, we show that depletion of 
a single p190 paralog is sufficient to induce alterations associated 
with oncogenic transformation when epithelial cells are cultured 
in Matrigel. Collectively, our data support a tumor-suppressor 
function for p190A through activation of canonical Hippo signal-
ing and inhibition of mechanotransduction to induce CIP.
Results
Analysis of ARH GAP35 mutations suggests p190A loss of 
function in epithelial cancers
ARH GAP35 mutations occur predominantly in epithelial cancers 
(Fig. 1 A). Analysis of the spectrum of mutations occurring in ARH 
GAP35 suggests a role as tumor suppressor. Approximately 40% of 
nonsynonymous ARH GAP35 mutations are nonsense or frame-shift 
mutations (Fig. 1 B). These mutations are scattered throughout the 
coding region, which is difficult to reconcile with a gain-of-func-
tion effect (Fig. 1 C). Instead, if ARH GAP35 were to exert tumor-sup-
pressor capacities, one might expect that a subset of tumors would 
exhibit loss of heterozygosity. To this end, we performed an anal-
ysis of somatic ARH GAP35 mutations in the PanCancer mutation 
dataset derived from ∼5,000 patients. This analysis revealed a wide 
range of mutant allele frequencies, with several tumors having 
mutant allele fractions >0.5, thus indicative of loss of heterozygos-
ity (Fig. 1 C). It should be noted that even among tumors with an 
allele fraction <0.5, many will likely exhibit loss of heterozygosity 
because tumor samples contain stromal and inflammatory compo-
nents. A tumor-suppressor function is also supported by the obser-
vation that ARH GAP35 is located in a region of chromosome 19, 
which frequently is focally deleted in carcinomas (Zack et al., 2013).
Depletion of p190 RhoGAP is sufficient to activate Rho 
signaling in epithelial cells
Next, to elucidate the effects of loss of p190A expression in epi-
thelial oncogenesis, we used immortalized, but nontumorigenic, 
diploid MDCK cells. This model permits a detailed analysis of 
the function of p190A in epithelial cells without confounding 
effects resulting from oncogenic transformation. We included 
the paralog p190B in this analysis because p190B is 50% identi-
cal to p190A, structurally highly similar, and coexpressed with 
p190A in most tissues and cell types. Using previously pub-
lished methods (Frank et al., 2012), we generated MDCK cells 
with doxycycline-inducible knockdown of p190A (p190A-kd), 
p190B (p190B-kd), or p190A combined with p190B (p190A+B-kd; 
Fig. 2 A). In this system, we achieved almost complete depletion of 
p190A and p190B (Fig. 2 B). Moreover, combinations of different 
shRNAs yielded highly effective knockdown of p190A and p190B 
(Fig. 2 C). Using these cell lines, we first determined the effects 
of depleting p190A and/or p190B on the activity of endogenous 
RhoA. To this end, we used the Rhotekin–Ras binding domain 
(RBD) pulldown assay to detect the active GTP-bound form of 
RhoA. p190A-kd or p190B-kd significantly increased cellular lev-
els of GTP-bound RhoA, whereas p190A+B-kd yielded a modest 
additional increase (Fig. 2 D). p190A has also been reported to 
act as a GAP for Rac proteins in an environment of acidic phos-
pholipids (Ligeti et al., 2004). However, using the PAK3-Cdc42/
Rac interactive binding (CRIB) pulldown assay, we observed 
no changes in Rac-GTP levels upon p190A-kd and/or p190B-kd 
(Fig. 2 E). Furthermore, depletion of p190A and/or p190B elicited 
potent actin-stress fiber and focal adhesion formation (Fig. 2 F), 
which is consistent with activation of RhoA.
p190A and p190B are essential for CIP in epithelial cells
Phase-contrast imaging of confluent p190A+B-kd cell cultures 
revealed formation of foci-like structures that were not observed 
with control, p190A-kd, or p190B-kd cells (Fig. S1 A). To elucidate 
the nature of these structures, we first examined dense cultures 
of p190A-kd and/or p190B-kd cells grown on permeable supports. 
Both p190A and p190B localized to adherens junctions, and indi-
vidual knockdown of p190A or p190B did not affect localization 
of the other paralog (Fig. 3 A). We next analyzed the effects of 
p190A and/or p190B depletion on epithelial architecture and 
included p190A+B-kd cells that had been reconstituted with 
either Myc-tagged, knockdown-resistant full-length p190A or 
p190A(ΔGAP), a mutant comprised of amino acids 1–1,228 and 
thus lacking the C-terminal GAP domain (Fig. 3 B). Knockdown 
of p190A or p190B individually had no major effects on epithelial 
architecture (Fig. 3 C). In contrast, p190A+B-kd cultures exhib-
ited abundant areas with cell multilayering, an effect that was 
rescued by expression of knockdown-resistant full-length p190A 
but not p190A(ΔGAP) (Figs. 3 C and S1 A). Phalloidin staining 
revealed that multilayered cells were piled up many layers high 
and that several foci-like structures of multilayered cells con-
tained lumens (Fig. S2, A–D). Combined knockdown of p190A and 
p190B also elicited extensive cell sloughing as demonstrated in 
cytospins of media harvested from cell cultures (Fig. S1 B). Again, 
these effects were rescued by expression of knockdown-resistant 
p190A but not p190A(ΔGAP) (Fig. S1 B). The sloughed cells were 
undergoing apoptosis as determined by TdT dUTP Nick-end 
labeling (TUN EL) staining (Fig. S1 B). Thus, sloughing may result 
from multilayered cells receiving insufficient survival signals 
upon segregation from the cell–substratum interface.
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Collectively, the data above suggest that cells with joint deple-
tion of p190A and p190B fail to undergo CIP. To test this possibility 
directly, we measured incorporation of BrdU in subconfluent and 
confluent cultures of MDCK cells. Although control, p190A-kd, 
and p190B-kd cells underwent quiescence at confluent density, 
p190A+B-kd cells continued to incorporate BrdU at high levels, 
similar to subconfluent cultures (Fig. 3, D and E). We confirmed 
these results independently by analysis of cyclin A levels, which 
were low in control, p190A-kd, and p190B-kd cells upon reaching 
saturation densities. In contrast, cyclin A levels remained high 
in dense cultures of p190A+B-kd cells (Figs. 3 F and S1, C and D). 
BrdU incorporation and cyclin A levels in p190A+B-kd cells were 
normalized by expression of knockdown-resistant full-length 
p190A but not p190A(ΔGAP) (Fig.  3, D–F). A p190A(R1284K) 
construct containing a function-ablating mutation in the essen-
tial arginine residue of the GAP domain, which also occurs in a 
patient tumor sample (TCGA-CV-7425), similarly failed to restore 
contact inhibition in cells depleted of p190A and p190B (Fig. 3, 
G–I). These results establish that p190A and p190B collectively 
are essential to mediate CIP, at least in part through their function 
as RhoGAPs. Moreover, the data show that perturbation of CIP in 
p190A+B-kd cells results in cell multilayering and cell sloughing.
Given that Rho proteins regulate the formation of junctional 
complexes in epithelial cells (Baum and Georgiou, 2011), we 
hypothesized that p190A and p190B might exert their effects 
on CIP through adherens and/or tight junctions. However, cad-
herin-mediated cell–cell adhesion remained intact after deple-
tion of p190A or p190B alone or together. This was indicated by 
localization of E-cadherin to membranes engaged in cell–cell 
contact (Fig. 3 C) as well as by aggregation assays (Fig. S3, A and 
B). Tight junctions were also intact after knockdown of p190A 
and/or p190B. This was determined by staining for the tight junc-
tion constituent ZO-1 and by measurements of transepithelial 
resistance (Fig. S3, C and D). Moreover, E-cadherin remained 
sequestered from the apical protein podocalyxin in p190A+B-kd 
cells (Fig. S3 E). Collectively, these results indicate that p190A 
and p190B do not promote CIP through major effects on cell–cell 
junctions or cell polarity.
p190A and p190B repress transcriptional activation by the 
Hippo transducer YAP
Both p190A and p190B have also been implicated in modulat-
ing transcriptional responses (Sordella et al., 2002; Jiang et al., 
2005). Therefore, we considered that loss of CIP in p190A+B-kd 
Figure 1. Mutations in ARH GAP35 encoding 
p190A in human cancer. (A) Frequency distri-
bution of ARH GAP35 mutations in different types 
of human cancer. Numbers refer to the following 
published studies: (1) Kandoth et al. (2013); (2) 
Cancer Genome Atlas Research Network (2014); 
(3) Bass et al. (2014); (4) Collisson et al. (2014); (5) 
Cancer Genome Atlas Research Network (2012); 
(6) Cancer Genome Atlas Network (2012); (7) Bell 
et al. (2011); (8) Cancer Genome Atlas Research 
Network (2013); (9) Cancer Genome Atlas 
Network (2012); (10) Lohr et al. (2014). MM, mul-
tiple myeloma. (B) Pie chart illustrating relative 
frequencies of missense, nonsense, and frame-
shift mutations as well as in-frame deletions 
and splice mutations in ARH GAP35 mutations in 
human cancer. (C) Diagram illustrating the loca-
tion of p190A mutations and relative frequencies 
of corresponding mutant ARH GAP35 alleles in 
tumor samples. Each point in the figure indicates 
an individual somatic mutation from a dataset 
derived from ∼5,000 cancer patients. The allele 
fraction of a given mutation is estimated based 
on the ratio between read counts of the alterna-
tive alleles versus the total read counts including 
both alternative alleles and reference alleles. We 
highlight mutations with loss-of-function con-
sequences (missense and nonsense/frameshift 
indel) with allelic fraction >0.5. RAS, GTPase 
domain; F, FF motifs; GAP, GAP domain.
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cells might result from effects on gene expression. To test this 
possibility, we conducted genome-wide mRNA sequencing 
(mRNA-seq) analyses on MDCK cells with or without knock-
down of p190A and/or p190B. These analyses were performed 
for both sparse and dense cultures. We focused on genes that 
exhibited altered expression in p190A+B-kd cells relative to con-
trol cells as well as cells with individual knockdown of p190A 
or p190B. Using criteria detailed in Materials and methods, we 
determined that 347 and 757 gene transcripts in dense cultures 
of p190A+B-kd cells were significantly up- and down-regulated, 
respectively (Tables S1 and S2). In sparse cultures of p190A+B-kd 
cells, 224 gene transcripts were up-regulated and another 224 
gene transcripts down-regulated (Tables S3 and S4). Strikingly, 
genes that ranked at the top among up-regulated genes in both 
datasets included several that previously have been associated 
with Hippo signaling (Aragona et al., 2013; Mohseni et al., 
2014). These genes include ANK RD1, PAI1, TGFB2, SLIT2, PDG 
FB, CYR61, SEMA7A, and RND3, which ranked 2, 3, 4, 8, 11, 13, 
18, and 28, respectively, in dense p190A+B-kd cells (Table S1). 
These and other genes selected for validation are shown in 
Fig. 4 A. Importantly, the majority of these genes were ranked 
highly in both dense and sparse cells (Fig. 4 A), consistent with 
p190A+B-kd cells exhibiting a defect in sensing cell density. 
Induced expression of top ranked genes in the transcriptome 
Figure 2. p190A and/or p190B repress Rho signaling in epithelial cells. (A) MDCK TR-T10 cells expressing inducible shRNAs targeting p190A and/or p190B. 
Cells were incubated with either vehicle or doxycycline (dox) to induce knockdown of gene expression. Cells were cultured for 3 d at sparse density to achieve 
optimal knockdown followed by 5 d at high density. Whole-cell lysates were then subjected to Western blotting to detect p190A, p190B, or ERK1/2. All other 
figures show data from doxycycline-treated cells only. (B) Whole-cell lysates from control cells were subjected to serial twofold dilution. These samples, along 
with undiluted lysates from p190A+B-kd cells, were processed for Western blotting to detect p190A, p190B, and ERK1/2. (C) Knockdown of gene expression 
using different combinations of shRNAs targeting p190A or p190B. (D) Effects of p190A and/or p190B depletion on cellular RhoA-GTP levels were measured by 
a Rhotekin–RBD pulldown assay. Data are presented as mean ± SD (n = 3); *, P < 0.05 (n = 3). (E) Rac1-GTP levels in cells with p190A-kd and/or p190B-kd were 
determined by a PAK3-CRIB pulldown assay. Data are presented as mean ± SD (n = 3); *, P < 0.05 (n = 3). Molecular masses are given as kilodaltons. (F) Control, 
p190A-kd, p190B-kd, or p190A+B-kd cells were processed to localize the focal adhesion constituent paxillin (green), incubated with Alexa Fluor 594–phalloidin 
to detect polymerized actin (red), and stained with the DNA-intercalating dye DRAQ5 to show nuclei (blue). Bar, 10 µm.
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of dense p190A+B-kd cells was validated by quantitative PCR 
(qPCR; Fig. 4 B).
To further test whether p190A and p190B modulate Hippo 
signaling in MDCK cells, we assayed the effects of knocking 
down p190A and/or p190B on localization of YAP, a transcrip-
tional coactivator that is a substrate of LATS kinases and a key 
transducer of Hippo signaling. Phosphorylation of YAP prevents 
its entry into the nucleus and thus inhibits its activity (Zhao et 
al., 2007). In control cells as well as p190A-kd or p190B-kd cells, 
we observed low to modest levels of YAP in the nuclear fraction 
isolated from confluent cell monolayers. In contrast, the amount 
of YAP was significantly increased in the nuclear fraction from 
p190A+B-kd cells (Fig. 4, C and D).
Current genome sequencing data do not support that p190A 
and p190B are simultaneously mutated and/or deleted in can-
cer. To address the possibility that p190A or p190B individually 
induces expression of genes modulated by the Hippo pathway, 
we chose human HEC-1-A uterine carcinoma cells for analysis 
because ARH GAP35 is highly mutated in uterine carcinoma 
(Fig. 1 A). Thus, we generated HEC-1-A cells with constitutive 
knockdown of p190A or p190B (Fig. 4 E). Indeed, depletion of 
either p190A or p190B was sufficient to augment expression of 
established Hippo-modulated genes including AMO TL2, ANK 
RD1, CTGF, CYR61, PAI1, RND3, and SEMA7A (Fig. 4 F). Expression 
of Hippo pathway–associated genes was also modestly up-regu-
lated in genome-wide analyses of MDCK cells depleted of p190A 
or p190B alone (Fig. 4 G). Collectively, these results demonstrate 
a role for p190A and p190B as essential modulators of YAP-regu-
lated gene expression in epithelial cells.
Finally, we were able to validate gene expression data by West-
ern blotting to the extent that antibodies cross-reactive with 
canine gene products could be obtained (Fig. 4 H). Interestingly, 
Figure 3. p190A and p190B are essential for CIP in epithelial cells. (A) p190A and p190B localize in part to adherence junctions in MDCK cells grown 
on permeable supports. Knockdown of p190A and/or p190B was achieved as described in the legend to Fig. 1 A. Cells were then fixed and labeled to detect 
E-cadherin (green) and p190A or p190B (red). Bar, 10 µm. (B) Expression of knockdown-resistant Myc-tagged p190A or p190A(ΔGAP), which is missing the 
C-terminal GAP-domain, in p190A+B-kd cells. Whole-cell lysates were processed for Western blotting to detect p190A, p190B, Myc epitope, and ERK. The 
lines between lanes 3 and 4 indicate omission of two lanes from the original gel. The omitted lanes contained samples with additional clones expressing 
knockdown-resistant Myc-tagged p190A or p190A(ΔGAP). (C) Depletion of p190A and p190B together, but not individually, elicits cell multilayering. Exoge-
nous expression of knockdown-resistant Myc-tagged p190A, but not a mutant from which the C-terminal GAP domain is deleted, restores normal epithelial 
architecture. Cells were labeled to localize E-cadherin (green) and podocalyxin (red); nuclei were stained with DRAQ5 (blue). Bars: (low magnification) 10 µm; 
(high magnification) 2 µm. (D) BrdU incorporation (red) in dense cultures of control, p190A-kd, p190B-kd, or p190A+B-kd cells as well as in p190A+B-kd cells 
expressing knockdown-resistant full-length p190A or GAP-deficient p190A(ΔGAP). Samples were counterstained with DAPI (blue) to detect cell nuclei. Bar, 
20 µm. (E) Quantification of BrdU incorporation data are presented as mean ± SD (n = 3); *, P < 0.01. s, subconfluent culture; c, confluent culture. (F) Cyclin A 
expression in dense cultures of control, p190A-kd, p190B-kd, or p190A+B-kd cells with or without expression of knockdown-resistant p190A or p190A(ΔGAP). 
Whole-cell lysates were processed for Western blotting to detect cyclin A and ERK. Data are presented as mean ± SD (n = 4); *, P < 0.02. (G) Expression of Myc-
tagged, knockdown-resistant, WT, or catalytically inactive p190A(R1284K) in MDCK cells depleted of p190A and p190B. Western blotting of whole-cell lysates 
was performed to detect Myc-epitope, p190A, p190B, and ERK1/2. (H) Cyclin A expression in whole-cell lysates from control and p190A+B-kd cells transduced 
with empty vector, Myc-tagged WT, or catalytically inactive p190A(R1284K). Molecular masses are given as kilodaltons. (I) Quantification by densitometry of 
cyclin A levels from the conditions described in H. The histograms show mean ± SD (n = 4).
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this included strongly induced expression of Rnd3, which interacts 
directly with p190A and p190B and enhances their GAP activity 
(Wennerberg et al., 2003). ROCK-phosphorylated Rnd3 has been 
demonstrated to stabilize adherens junctions by sequestering 
p190B in the cytosol (Priya et al., 2015). However, Rnd3 evidently 
cannot exert this function in the absence of p190B, which may 
explain why adherens junctions appear intact in cells depleted of 
p190A and/or p190B. Rnd3 has moreover been implicated in pro-
moting CIP (Hernández-Sánchez et al., 2015). Evidently, in spite 
of strongly induced expression of Rnd3, p190A+B-kd cells fail to 
reach quiescence at high cell density. Hence, if Rnd3 promotes CIP 
in MDCK cells, it may execute this function through its established 
effector proteins p190A and/or p190B.
p190A and p190B promote CIP through inhibition of YAP-
mediated gene transcription
YAP serves as a coactivator for TEAD family transcription factors 
(Vassilev et al., 2001). Phosphorylation of YAP on five serines, 
Figure 4. p190A and p190B repress expression of genes associated with the Hippo pathway. (A) Genome-wide mRNA-seq analyses from MDCK cells 
depleted of p190A and p190B expression reveal strong induction of genes associated with Hippo signaling in both dense and sparse cultures. The data are rep-
resented as x–y plots with relative gene expression levels in control cells and p190A+B-kd cells on the abscissa and ordinate, respectively. Red dots correspond 
with individual genes with differential gene expression between p190A+B-kd and control cells using a threshold of log2(fold change) ≥1 and adjusted P value 
≤0.05. Genes selected for further validation as well as ARH GAP35 (two splice forms) and ARH GAP5 genes encoding p190A and p190B, respectively, are listed 
as a–o and marked individually as black dots. (B) Validation of transcriptomes from dense cultures of control, p190A-kd, p190B-kd, and p190A+B-kd cells by 
qPCR analysis. p190A and p190B depletion was achieved by three distinct combinations of shRNAs targeting p190A and p190B. Data are presented as mean ± 
SD (n = 3). (C) Knockdown of p190A and p190B promotes nuclear accumulation of YAP as determined by Western blotting to detect YAP1 in the nuclear fractions 
as well as p190A, p190B, and total YAP1 in the cytosolic fraction. (D) Quantification of nuclear YAP1 levels in dense cultures of control, p190A-kd, p190B-kd, 
or p190A+B-kd cells. Data are presented as mean ± SD (n = 4); *, P < 0.02. (E) Depletion of p190A or p190B in HEC-1-A uterine carcinoma cells as determined 
by Western blotting to detect p190A, p190B, and ERK. (F) Heat map representing relative fold change (linear scale) in gene expression levels in HEC-1-A cells 
depleted of p190A or p190B. Four distinct shRNAs (A1–A4) targeting p190A and two distinct shRNAs (B1 and B2) targeting p190B were used in this experiment. 
(G) Transcriptomes from MDCK cells depleted of either p190A or p190B expression show modest induction of Hippo-associated genes relative to control cells. 
The data are presented as described in A. Knockdown of either p190A or p190B expression was induced for 3 d at sparse cell density followed by replating at 
high cell density and continued culture for another 3 d, after which gene expression analysis was performed. The red dots correspond with individual genes 
with differential gene expression between p190A-kd or p190B-kd and control cells using a threshold of |log2(fold change)| ≥1 and adjusted P value ≤0.05. 
Genes are listed as a–o and marked individually as described in A. (H) Validation of gene expression elicited by depletion of p190A and/or p190B by Western 
blotting using antibodies specific for Dock4, Esm1, Pai-1, and Rnd3 with ERK1/2 as control for equal protein loading. Molecular masses are given as kilodaltons. 
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including S127 and S397, prevents its entry into the nucleus and 
promotes its degradation by the β-TRCP E3-ligase (Zhao et al., 
2007, 2010). Mutation of each of these five serines to alanine gen-
erates a YAP5SA mutant that is constitutively active (Zhao et al., 
2007). Introduction of an additional S94A mutation in YAP5SA 
yields YAP5SA+S94A, which no longer can bind to TEAD family 
transcription factors and serves as a dominant inhibitory mutant 
(Zhao et al., 2008). To better define the extent to which p190A 
and p190B regulate transcription of Hippo-associated genes, we 
generated MDCK cells expressing YAP5SA (Fig. 5 A). We then per-
formed mRNA-seq analysis to directly compare gene expression 
induced by YAP5SA to that of p190A+B-kd in the same experi-
ment. Strikingly, ANK RD1, CYR61, ESM1, PAI1, RND3, SEMA7A, 
and SLIT2 were all strongly induced in both YAP5SA-expressing 
and p190A+B-kd cells (Fig. 5 B). To further validate that p190A and 
p190B repress YAP-mediated gene transcription, we generated 
MDCK cells expressing YAP5SA+S94A with or without knockdown 
of p190A and p190B (Fig. 5 A) and assayed the effects on transcript 
levels of the bona fide YAP target genes ANK RD1 and CYR61. 
Expression of YAP5SA+S94A strongly reduced expression levels 
of ANK RD1 and CYR61 transcripts in p190A+B-kd cells (Fig. 5 C).
Next, we tested whether the capacity of p190A and p190B to 
repress YAP-mediated gene transcription is responsible for CIP 
in epithelial cells. Expression of YAP5SA alone led to loss of CIP 
as indicated by increased expression of cyclin A and elevated 
BrdU incorporation at high cell density, effects that mimic those 
observed in p190A+B-kd cells (Fig.  5, A and D). Moreover, as 
previously described (Zhao et al., 2011), expression of YAP5SA 
in MDCK cells elicited extensive cell multilayering (Fig. 5, E and 
F). In contrast, expression of YAP5SA+S94A in p190A+B-kd cells 
effectively reduced both cyclin A levels and BrdU incorporation 
in comparison with p190A+B-kd cells (Fig. 5, A and D). Expres-
sion of YAP5SA+S94A moreover attenuated multilayering in 
cultures of p190A+B-kd cells (Fig. 5, E and F). Collectively, these 
data establish that p190A and p190B induce CIP by repressing 
YAP-mediated gene transcription.
Rho–ROCK signaling is required for loss of CIP in MDCK cells 
depleted of p190A and p190B
Mechanotransduction by Rho–ROCK-dependent actomyosin 
contractility has previously been shown to induce expression of 
YAP-regulated genes (Berenjeno et al., 2007; Dupont et al., 2011). 
Therefore, we tested whether Rho–ROCK signaling was sufficient 
and/or required for YAP-mediated gene transcription and loss 
of CIP in MDCK cells. To mimic the loss of RhoGAP activity, we 
generated MDCK cells with doxycycline-inducible expression of 
“fast-cycling” RhoA(F30L) (Fig. 6 A). Expression of RhoA(F30L) 
led to a major increase in RhoA-GTP levels and potent formation 
of actin stress fibers (Fig.  6, A and B). However, RhoA(F30L) 
expression did not perturb CIP as indicated by the absence of cell 
multilayering, foci-like structures or increased BrdU incorpora-
tion (Fig. 6, B–D). In addition, expression of RhoA(F30L) did not 
induce expression of ANK RD1 or CYR61 (Fig. 6 E). These results 
are consistent with published studies on MDCK cells, which 
demonstrate that expression of constitutively active forms of 
RhoA, G14V, and Q63L do not induce cell multilayering (Takaishi 
et al., 1997; Jou and Nelson, 1998; Hansen et al., 2000).
We then sought to determine whether Rho signaling is required 
for bypassing CIP in confluent cultures of p190A+B-kd cells. Var-
ious attempts to achieve stable or inducible expression of domi-
nant negative RhoA in MDCK cells were unsuccessful. Instead, we 
used Tat-derivatized and Myc-tagged Clostridium botulinum C3 
(Tat-Myc-C3) toxin to acutely inactivate endogenous Rho proteins. 
Upon overnight incubation, Tat-Myc-C3 toxin entered p190A+B-kd 
cells and efficiently depleted RhoA-GTP levels (Fig. 7 A). Treatment 
with Tat-Myc-C3 toxin strongly reduced expression of ANK RD1 
and CYR61 induced by p190A+B-kd (Fig. 7 B). It moreover led to 
dramatic sloughing of cells depleted of p190A and p190B, thus 
demonstrating that Rho signaling is required not only for bypass 
of CIP but also for survival of multilayered cells. Given that the 
integrity of sloughed cells is disrupted, we used Western blotting 
for extracellular signal-related kinase (ERK) protein from har-
vested cell culture medium as a proxy readout for the amounts of 
sloughed cells. Treatment with Tat-Myc-C3 toxin led to a signifi-
cant increase in the amount of cell sloughing in p190A+B-kd cells 
(Fig. 7 C). Moreover, the sloughed cells were undergoing apoptosis 
as indicated by a significant increase in the amount of cleaved poly 
(ADP-ribose) polymerase (PARP) protein in medium harvested 
from p190A+B-kd cells after incubation with Tat-Myc-C3 toxin 
(Fig. 7 C). Confocal microscopy demonstrated that cell multilay-
ering was substantially reduced after treatment with Tat-Myc-C3 
toxin (Fig. 7 D). Collectively, these results demonstrate that Rho 
signaling is essential for YAP-regulated gene transcription, pro-
tection against apoptosis, and cell multilayering in MDCK cells 
depleted of p190A and p190B. It should be noted that it was not for-
mally possible to assess CIP in cells treated with C3 toxin because 
of toxicity upon prolonged exposure.
Next, we tested a requirement for ROCK signaling in loss of 
CIP and YAP-mediated gene transcription in MDCK cells depleted 
of p190A and p190B. Incubation of confluent p190A+B-kd cells 
with a range of 5–20 µM of the ROCK inhibitor Y-27632 for 24 h 
yielded substantial concentration-dependent reductions in the 
expression of ANK RD1 and CYR61 (Fig. 7 E). Furthermore, pro-
longed treatment of p190A+B-kd cells with 20 µM Y-27632 sig-
nificantly reduced BrdU incorporation (Fig. 7 F) as well as cyclin 
A levels (Fig. S4, A and B). In addition, incubation with ROCK 
inhibitor attenuated multilayering in p190A+B-kd cell cultures 
(Figs. 7 G and S4 C). In comparison, the effects of inhibiting 
Rho–ROCK signaling in MDCK cells without depletion of p190A 
and p190B were relatively subtle (Fig. S4, D–G). Collectively, our 
results are consistent with the conclusion that p190A and p190B 
modulate YAP-mediated gene expression and associated cellular 
effects in a manner for which Rho–ROCK signaling is essential.
Modulation of CIP and YAP-mediated gene expression by 
p190A and p190B is LATS dependent
The data presented above demonstrate that Rho–ROCK sig-
naling is required but not sufficient to promote YAP-mediated 
gene transcription in MDCK cells depleted of p190A and p190B. 
YAP is a substrate of the AGC family kinases LATS1 and LATS2, 
and canonical Hippo signaling is defined as LATS1/2 dependent 
(Meng et al., 2016). To determine whether p190A and p190B 
modulate Hippo signaling in MDCK cells, we performed Western 
blots for phospho-S909/S872 in the activation loop of LATS1/2. 
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Depletion of p190A or p190B alone did not elicit major effects on 
phosphorylation of S909/S872 in LATS1/2 in confluent mono-
layers. However, combined knockdown of p190A and p190B led 
to a significant decrease in LATS1/2 S909/S872 phosphorylation 
(Fig. 8, A and B). Thus, expression of p190A and p190B is required 
for LATS1/2 phosphorylation in MDCK cells.
We then sought to establish whether LATS1/2 activation 
is necessary for p190A to promote CIP and repress YAP-me-
diated gene transcription. Specifically, we asked whether the 
induction of CIP and attenuation of YAP-regulated gene tran-
scription in p190A+B-kd cells by knockdown-resistant p190A 
is LATS dependent. To this end, we engineered control or 
Figure 5. p190A and p190B promote CIP by repressing YAP-mediated gene transcription. (A) Expression of constitutively active YAP5SA or dominant-neg-
ative YAP5SA+S94A in control and p190A+B-kd MDCK cells. Western blotting of whole-cell lysates was performed to detect YAP1, cyclin A, p190A, p190B, and 
ERK. Molecular masses are given as kilodaltons. (B) mRNA-seq transcriptomes from dense cultures of MDCK cells expressing constitutively active YAP5SA 
and from p190A+B-kd cells were derived from samples processed concomitantly to permit direct comparison. The data are represented as described in the 
legend to Fig. 5 A. (C) qPCR analysis of ANK RD1 and CYR61 expression in control and p190A+B-kd cells with or without expression of YAP5SA or YAP5SA+S94A. 
Data are presented as mean ± SD (n = 3). (D) BrdU incorporation in dense cultures of control and p190A+B-kd cells with or without expression of YAP5SA or 
YAP5SA+S94A. Data are presented as mean ± SD (n = 4); *, P < 0.01. (E) Phase-contrast imaging of control, YAP5SA, YAP5SA+S94A, and p190A+B-kd cells as 
well as p190A+B-kd cells expressing YAP5SA+S94A. Bar, 50 µm. (F) Confocal microscopy of control, YAP5SA, and p190A+B-kd cells as well as p190A+B-kd 
cells expressing YAP5SA+S94A. Cells were labeled to detect Scrib (green) and podocalyxin (red), and nuclei were stained with DRAQ5 (blue). Bars, 10 µm.
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p190A+B-kd cells to express HA-tagged kinase-dead murine 
LATS2(K655R), abbreviated as LATS2-KR, upstream of an 
IRES-ZsGreen cassette (Fig. 8 C). Expression of LATS2-KR to 
interfere with endogenous LATS signaling has been devised 
and validated previously (Zhao et al., 2007). Using this strategy 
for MDCK cells cultured on permeable supports, we found that 
expression of LATS2-KR in p190A+B-kd cells perturbed the 
capacity of exogenous knockdown-resistant p190A to restore 
CIP and suppress YAP-mediated gene transcription (Fig.  8, 
C–E). Moreover, in p190A+B-kd cells restored with exogenous 
knockdown-resistant p190A, expression of LATS2-KR elic-
ited cell multilayering (Fig.  8  F). In contrast, expression of 
LATS2-KR on its own did not perturb CIP or affect YAP-regu-
lated gene expression in MDCK cells. Thus, neither cyclin A lev-
els nor ANK RD1 or CYR61 transcripts were noticeably altered 
by LATS2-KR expression alone, which moreover did not impact 
epithelial architecture detectably (Fig. 8, C–F). The latter result 
is consistent with mechanotransduction serving a permissive 
role for LATS signaling to YAP as demonstrated previously 
(Aragona et al., 2013); i.e., in the absence of strong cytoskel-
etal tension, inhibition of LATS is insufficient to drive YAP 
activation. Collectively, the data demonstrate that in addition 
to modulating mechanotransduction, p190A controls CIP via 
canonical, i.e., LATS-dependent, Hippo signaling. These results 
may furthermore explain why Rho signaling, while required 
for loss of CIP in response to p190A+B-kd, is not sufficient to 
promote YAP-mediated gene transcription and bypass CIP in 
cells depleted of p190A and p190B.
Both p190A and p190B are required for epithelial architecture 
of MDCK cells cultured in Matrigel
Cells with preserved epithelial characteristics such as MDCK 
cells form cysts when suspended individually and propagated in 
Matrigel. Hippo signaling is highly context dependent. There-
fore, as an alternative to permeable supports, we tested the 
effects of p190A and/or p190B depletion in MDCK cells cultured 
in Matrigel. Strikingly, although control cells formed cysts with 
well-defined lumens, depletion of p190A or p190B alone or com-
bined resulted in a significant increase in spheroid size indica-
tive of perturbation of CIP (Fig. 9, A and B). Moreover, spheroids 
formed by p190A- and/or p190B-depleted MDCK cells were for 
the most part solid and thus without well-defined lumens, a trait 
associated with transformation of epithelial cells (Fig. 9 C). The 
formation of largely solid spheroids from cells with knockdown 
of p190A and/or p190B correlated with nuclear translocation of 
YAP (Fig. 9 D). This was most evident from optical sections sam-
pled from the periphery of spheroids but was also clearly visible 
when sectioning through the center (Fig. S5 A). The sufficiency 
of individual p190A or p190B knockdown in eliciting nuclear 
translocation of YAP and perturbation of CIP in cells grown in 
Matrigel underscores the established importance of extracellular 
matrix in modulation of Hippo signaling (Serrano et al., 2013). 
Consistent with mechanical properties of Matrigel playing a key 
role in influencing the balance between canonical Hippo signal-
ing and mechanotransduction, expression of LATS2-KR alone in 
MDCK cells led to formation of mostly solid spheroids with larg-
er-than-normal diameter (Fig. 9 E).
Figure 6. Active RhoA is not sufficient to perturb CIP or 
induce expression of YAP-regulated genes. (A) RhoA-GTP 
levels in MDCK cells expressing EGFP-tagged fast-cycling 
RhoA(F30L) or EGFP only relative to p190A+B-kd or control 
cells. GTP-bound RhoA was precipitated by a Rhotekin–RBD 
pulldown assay followed by immunoblotting to detect active 
and total RhoA as well as GFP, cyclin A, and ERK. Molecular 
masses are given as kilodaltons. (B) Effects of expressing EGFP-
RhoA(F30L) (green) on actin stress fiber formation detected by 
staining with Alexa Fluor 594–phalloidin (white). Nuclei were 
labeled with DRAQ5 (blue). Bar, 10 µm. (C) Phase images of 
cells expressing EGFP-RhoA(F30L) or EGFP only. Bar, 50 µm. 
(D) BrdU incorporation in dense monolayers of cells expressing 
EGFP-RhoA(F30L) or EGFP only. p190A+B-kd and control cells 
were included for comparison. Data are presented as mean ± 
SD (n = 4); *, P < 0.02. (E) qPCR analysis of ANK RD1 and CYR61 
expression in cells expressing EGFP-RhoA(F30L) or EGFP only 
relative to p190A+B-kd or control cells. Data are presented as 
mean ± SD (n = 3).
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In spite of the striking effects of individual p190A/B knock-
down on spheroid architecture in Matrigel, we observed no 
major effects on adherens junctions consistent with findings 
for cells grown on permeable supports. Moreover, cells fac-
ing mostly small and/or slit-shaped lumens in p190A- and/or 
p190B-depleted spheroids exhibited strong subluminal phalloi-
din staining, a characteristic of apical membranes in epithelial 
cysts (Fig. 9 C). In such cells, Scrib was confined to membranes 
engaged in cell–cell contact. E-cadherin and β-catenin were sim-
ilarly localized to membranes engaged in cell–cell contact (Fig. 
S5 B). Collectively, the data obtained with MDCK cells cultured 
in Matrigel point to an essential role for p190A and p190B to con-
trol CIP by impacting Hippo signaling and are consistent with a 
tumor-suppressor role for p190A in epithelial cells.
Discussion
Two recent comprehensive studies identified ARH GAP35, which 
encodes p190A RhoGAP, as a major human cancer gene (Kandoth 
et al., 2013; Lawrence et al., 2014). This observation was unex-
pected because ARH GAP35 had not been strongly linked to can-
cer, and yet it ranked among the top 30 cancer genes. The high 
frequency of nonsense and frame-shift mutations in ARH GAP35 
is indicative of a role for p190A as tumor suppressor. Importantly, 
the ARH GAP35 locus is found in a region of the human genome 
that is frequently lost in tumors (Zack et al., 2013). Thus, loss-of-
function mutations in one allele of ARH GAP35 may be sufficient 
to eliminate p190A signaling in such tumors. This hypothesis is 
validated by our demonstration that loss-of-function mutations 
occur in human tumors with loss of heterozygosity. Previously, 
p190A was shown to suppress Ras-induced transformation of 
NIH3T3 fibroblast cells (Wang et al., 1997) as well as to inhibit 
PDGF-induced glioma formation in mice (Wolf et al., 2003). 
Recently, loss-of-function mutations in p190A were also linked 
to impairment of directional motility (Binamé et al., 2016). How-
ever, cellular functions of p190A consistent with a tumor-sup-
pressor role are not well defined.
In this study, we demonstrate that p190A and its paralog p190B 
play an essential role in CIP, an established barrier for oncogenic 
transformation (Hanahan and Weinberg, 2011). A detectable 
fraction of both p190A and p190B localize to lateral membranes 
of polarized MDCK cells. A simple mechanism whereby p190A 
and p190B might promote CIP would be to induce and/or enhance 
RhoA-dependent formation of adherens and/or tight junctions. 
However, depletion p190A and p190B does not appear to perturb 
cell–cell junctions or cell polarity. In absence of such effects, we 
considered the possibility that p190A and p190B might affect 
gene transcription as there is precedent in the literature for 
such a role (Sordella et al., 2002; Jiang et al., 2005). We deter-
mined that p190A and p190B repress expression of a cassette of 
Figure 7. Rho–ROCK signaling promotes YAP-mediated gene transcription and loss of CIP in cells depleted of p190A and p190B. (A) Delivery of Tat-
Myc-C3 transferase (Tat-Myc-C3) protein to p190A+B-kd cells. Control or p190A+B-kd cells were incubated with estimated equal amount of GST only or cleaved 
Tat-Myc-C3 for 18 h. Western blotting of whole-cell lysates was performed to detect Tat-Myc-C3 protein as well as p190A, p190B, RhoA, ERK1/2, and cleaved 
PARP fragment. Lysates of detached cells and cellular fragments were processed for Western blotting to detect ERK1/2 and cleaved PARP fragment. Moreover, 
RBD pulldown was performed to detect levels of Rho-GTP in parallel cultures. Molecular masses are given as kilodaltons. (B) qPCR analysis of ANK RD1 and 
CYR61 expression in control and p190A+B-kd cells with or without uptake of Tat-Myc-C3 protein. Data are presented as mean ± SD (n = 3). (C) Quantification 
by densitometry of relative amounts of ERK1/2 and cleaved PARP protein in medium harvested from control and p190A+B-kd cells incubated with GST only 
or cleaved Tat-Myc-C3. (D) Confocal microscopy of control and p190A+B-kd cells with or without incubation with Tat-Myc-C3 protein. Cells were labeled to 
detect E-cadherin (green) and podocalyxin (red), and nuclei were stained with DRAQ5 (blue). (E) qPCR analysis of mRNA levels in control and p190A+B-kd cells 
treated with 0–20 µM ROCK inhibitor Y-27632 for 24 h. (F) BrdU incorporation in control or p190A+B-kd cells incubated with 0 or 20 µM Y27632 for 3 d at low 
cell density followed by 5 d at high cell density. Data are presented as mean ± SD (n = 4); *, P < 0.02. (G) Confocal microscopy of control and p190A+B-kd cells 
as well as p190A+B-kd cells treated with 20 µM Y-27632 during 5 d of culturing on permeable supports. Bars, 10 µm.
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genes that are regulated by the transcriptional coactivator YAP, 
a transducer of the Hippo pathway (Camargo et al., 2007; Dong 
et al., 2007). Accordingly, depletion of p190A and p190B expres-
sion elicits translocation of YAP to the nucleus and activation of 
a YAP-dependent transcriptional program. We demonstrate that 
suppression of YAP-regulated gene transcription underlies the 
capacity of p190A and p190B to induce CIP. This result is con-
sistent with a tumor-suppressor function of p190A as YAP is an 
oncoprotein that plays a pivotal role in human cancer (Moroishi 
et al., 2015; Zanconato et al., 2016).
YAP activity is regulated by both the canonical Hippo pathway 
and by mechanotransduction, which is defined as ROCK depen-
dent (Dupont et al., 2011; Aragona et al., 2013). Our data demon-
strate that in MDCK cells, p190A and p190B promote hydrolysis 
of GTP-bound RhoA but not Rac1. We moreover show that cata-
lytic activity is essential for exogenous p190A to induce CIP in 
dense epithelial cell cultures depleted of endogenous p190A and 
p190B. Furthermore, we establish that Rho–ROCK signaling plays 
a major role in eliciting transcription of YAP-regulated genes 
upon knockdown of p190A and p190B. However, elevated cellular 
levels of GTP-bound RhoA alone are not sufficient to bypass CIP 
as cells expressing highly active fast-cycling RhoA fail to promote 
transcription of YAP-regulated genes and undergo quiescence at 
high cell density. Moreover, we and others have not observed loss 
of CIP upon expression of constitutively active forms of RhoA in 
MDCK cells (Takaishi et al., 1997; Jou and Nelson, 1998; Hansen 
et al., 2000). Therefore, in addition to catalytic activity, nonen-
zymatic functions, i.e., scaffolding activities of p190A and p190B, 
are required for inducing CIP in dense cultures. Such scaffolding 
activities likely act upstream of LATS as indicated by our demon-
stration that p190A and p190B promote LATS activation and 
that LATS is required for induction of CIP in p190A+B-kd cells 
reconstituted with knockdown-resistant p190A. Fig. 10 presents 
a model for how p190 RhoGAPs control CIP based on our current 
knowledge. Further work is required to define scaffolding func-
tions of p190 RhoGAPs, an arduous undertaking given the sheer 
size and relative scarcity of defined structural domains.
In this work, we relied on a nononcogenically transformed epi-
thelial cell system to study the role of p190A and p190B in CIP. This 
is essential because carcinoma cells exhibit loss of CIP to varying 
degrees. The data reveal that p190A and p190B possess similar 
functions to repress YAP-mediated transcription and induce CIP in 
epithelial cells. The apparent redundancy may confer an additional 
level of safeguarding against deregulated growth resulting from 
loss of a single paralog. However, only ARH GAP35 encoding p190A 
is significantly mutated or lost in cancer. This raises the question 
Figure 8. p190A and p190B activate LATS, and p190A promotes CIP in a LATS-dependent manner. (A) Depletion of p190A and p190B inactivates LATS. 
pLATS1/2 refers to both LATS1(pS909) and LATS2(pS872) because the antibody does not distinguish between the two paralogs. (B) Quantification of phos-
pho-LATS1/2 levels in dense cultures of control, p190A-kd, p190B-kd, or p190A+B-kd cells. (C) Expression of knockdown-resistant p190A in p190A+B-kd cells 
promotes CIP in a LATS-dependent manner. Molecular masses are given as kilodaltons. (D) Quantification of cyclin A levels in control and p190A+B-kd cells 
with or without expression of knockdown-resistant p190A and with and without expression of kinase-dead LATS2(K655R) (LATS2-KR). Data are presented as 
mean ± SD (n = 4); *, P < 0.02. (E) qPCR analysis of ANK RD1 and CYR61 expression in control and p190A+B-kd cells with or without expression of LATS2-KR. 
Data are presented as mean ± SD (n = 3). (F) Confocal microscopy of control and p190A+B-kd cells without or with expression of knockdown-resistant p190A 
as well as with and without expression of LATS2-KR. Cells were stained with Alexa Fluor 594–phalloidin and DRAQ5 to detect polymerized actin (red) and nuclei 
(blue). Cells expressing LATS2-KR coexpress ZsGreen from an IRES cassette (green). Bars, 10 µm.
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of why loss of p190A but not p190B might initiate, promote, and/or 
sustain oncogenic transformation. The catalytic activity of p190B is 
higher than that of p190A (Vincent and Settleman, 1999). Accord-
ingly, p190B may not be dispensable for cancer cell survival. Indi-
vidual knockdown of p190A or p190B is sufficient to elicit modest 
increases in transcription of YAP-regulated genes in both MDCK 
cells and HEC-1-A uterine carcinoma cells. These results suggest 
that there is a threshold for induced expression of YAP-regulated 
genes to bypass CIP, which is reached in MDCK cells cultured on 
permeable supports only upon combined depletion of p190A and 
p190B but not individual depletion. However, in cells with acti-
vating mutations in oncogenes or loss-of-function mutations in 
tumor-suppressor genes, the threshold for inducing loss of CIP may 
be lower and loss of p190A expression therefore sufficient.
p190A and p190B exhibit 50% sequence identity but also large 
stretches of divergent sequence and separate modes of regula-
tion. Another possibility is that in epithelial cells undergoing 
oncogenic transformation, p190B expression, localization, and/
or activity may be altered in a manner that leaves the cell more 
responsive to loss of p190A. Alternatively, ARH GAP35 mutations 
may occur at a later stage when cancer cells are surrounded by 
a more rigid matrix, which lowers the threshold for robust YAP 
activation through inhibition of the canonical Hippo pathway. 
Our results obtained with culturing MDCK cells in Matrigel are 
compatible with this scenario. In this setting, loss of a single p190 
paralog is sufficient to elicit architectural changes associated 
with oncogenic transformation. It is pertinent to direct future 
studies to better understand the role of ARH GAP35 as a major 
Figure 9. Both p190 RhoGAP paralogs are required for normal epithelial architecture of MDCK cells propagated in Matrigel. (A) Outlines of median-size 
spheroids derived from MDCK cells with or without depletion of p190A and/or p190B cultured in Matrigel for 14 d. (B) Size (area) distribution of spheroids with 
or without p190A and/or p190B knockdown after 14 d of culture in Matrigel. The areas from ≥40 cysts from each condition were measured. (C) Immunolabeling 
for Scrib (green) and phalloidin staining to detect polymerized actin (red) in spheroids with or without p190A and/or p190B depletion after 10 d of culture 
in Matrigel. Nuclei were stained with DRAQ5 (blue). Bars: (low magnification) 10 µm; (inset) 2.5 µm. (D) Localization of YAP in MDCK cell spheroids with or 
without knockdown of p190A and/or p190B after 14 d of culture in Matrigel. The images for YAP (white) were superimposed on the DRAQ5 stain (blue) using 
the screen function in Photoshop. Optical sections close to the perimeter of spheroids are shown. Bars: (low magnification) 20 µm; (inset) 5 µm. (E) Staining 
of LATS2-KR–expressing MDCK cells cultured for 14 d in Matrigel with Alexa Fluor 594–phalloidin to detect polymerized actin (red) and DRAQ5 to label nuclei 
(red). LATS2 and ZsGreen are coexpressed from a bicistronic vector. Bar, 20 µm.
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novel cancer gene and use this information to develop person-
alized therapeutics for cancer. In this context, the potential to 
perturb the YAP–TEAD interaction as demonstrated previously 
(Liu-Chittenden et al., 2012; Jiao et al., 2014) may prove relevant 
in tumors with loss-of-function mutations in ARH GAP35.
Materials and methods
Reagents
The following reagents were used for this work: BrdU (Sig-
ma-Aldrich); doxycycline (Sigma-Aldrich); DAPI (Thermo Fisher 
Scientific); DRAQ5 (Biostatus); FluorSave (EMD Millipore); 
FuGENE6 (Promega); phalloidin Alexa Fluor 594 (Thermo Fisher 
Scientific); PageRuler prestained protein ladder 10–180 kD 
(Thermo Fisher Scientific); EDTA-free Pierce protease inhibitor 
tablets (Thermo Fisher Scientific); and ROCK inhibitor (Y-27632; 
Sigma-Aldrich).
Antibodies
Antibodies used for this study are listed in Table 1. Secondary 
antibodies purchased from Invitrogen were as follows: goat 
anti–mouse/Alexa Fluor 488; goat anti–mouse/Alexa Fluor 555; 
goat anti–rabbit/Alexa Fluor 488; goat anti–rat/Alexa Fluor 488; 
goat anti–mouse/HRP; and goat anti–rabbit/HRP.
Preparation of Tat-Myc-C3 transferase protein
Tat-Myc-C3 transferase was cloned into pGEX TEV vector (gift 
from K. Orth, University of Texas Southwestern, Dallas, TX). 
Plasmid was transformed into Rosetta2DE3pLYS bacterial cells, 
plated on Luria-Bertani agar plates, and incubated at 37°C over-
night. The next day, bacteria scraped from the plates were used 
for a starter culture and incubated for 3–4 h at 37°C. The starter 
culture was inoculated to larger flasks at a 1:100 volume ratio 
and grown to OD600 = 0.6–1.0. Protein expression was induced 
with 0.4 mM IPTG, and the bacteria were grown for 16 h at RT. 
The next day, the bacteria were spun at 6,000 g for 10 min and 
harvested and resuspended in 20 mM Tris, pH 8, 150 mM NaCl, 
0.5% Triton X-100, and 1 mM PMSF. The bacterial suspension was 
lysed with Emulsiflex-C3 (Avestin). The lysate was centrifuged at 
15,000 g for 10 min, and supernatant was transferred to a tube 
containing glutathione resin (Goldbio) and incubated at 4°C on 
a rotating platform for 1 h. The supernatant was removed, and 
the beads were transferred to an Econo-Pac column (Bio-Rad 
Laboratories) and washed with 20 mM Tris, pH 8, 150 mM NaCl, 
and 0.5% Triton X-100. Next, to cleave the GST moiety, His-TEV 
protease was added and incubated at 4°C overnight. The next 
day, cobalt agarose resin (Goldbio) was added to remove His-TEV 
protease, and flow-through containing cleaved Tat-Myc-C3 toxin 
was collected. The protein was dialyzed to 20 mM Tris, pH 8, and 
150 mM NaCl, and aliquots were flash-frozen with liquid nitro-
gen and stored at −80°C.
Cell culture
TR-T10 MDCK cells permitting conditional knockdown of gene 
expression have been described previously (Frank et al., 2012). 
TR-T10 cells as well as retroviral and lentiviral 293 packaging 
cells were propagated in DMEM supplemented with 10% FBS, 
and HEC-1-A cells were grown in McCoy’s medium supplemented 
with 10% FBS. For culture in Matrigel, ∼3,000 cells were mixed 
thoroughly in 30  µl ice-cold Matrigel and placed onto colla-
gen-coated coverslips for 15–30 min to harden before addition of 
cell culture medium. Cysts/spheroids were cultured for 10–14 d 
before fixation, labeling, and imaging.
Plasmid constructs
For RNA interference, complementary 80–87-base oligonucle-
otides containing BglII and HindIII overhangs were annealed 
and cloned into tetracycline-inducible pReSI-H1-Puro or pRe-
SI-H1-Hygro retroviral expression vectors described previously 
(Frank et al., 2012). Sequences of shRNA sense oligonucleotides 
used for MDCK cells in this work are as follows: canine p190A 
shRNA 1, 5′-GAT CCC GGA ACA GCG ATT TAA AGC ATT GCC CGG GCC 
GCC CTC AAT GCT TTA AAT CGC TGT TCC TTT TTT GGA ATC GATA-3′; 
and shRNA 2, 5′-GAT CCC GCA CCT TAG TGC AAC TCA TTG GCC CGG 
GCC GCC CTC CAA TGA GTT GCA CTA AGG TGC TTT TTT GGA ATC 
GATA-3′; canine p190B shRNA 1, 5′-GAT CCC GGA CGA GTA GTA 
AAC AAT GTT GCT TCC TGT CAC AAC ATT GTT TAC TAC TCG TCC TTT 
TTT GGA ACT CGA GA-3′; and shRNA 2, 5′-GAT CCC GGT AAC TGT 
Figure 10. Model illustrating the role of p190 RhoGAPs to promote 
CIP by repressing YAP activity. This cartoon summarizes our findings for 
how p190A and p190B modulate CIP through effects on YAP-regulated gene 
transcription in MDCK cells cultured on permeable supports. Left: A cell with 
normal expression of p190A and p190B. The activities of p190 RhoGAPs in 
this context are dual. The catalytic function of p190 proteins represses Rho–
ROCK signaling to attenuate mechanotransduction signals. Concomitantly, 
most likely through scaffolding activities, p190 proteins inhibit LATS activa-
tion. The net result is repression of YAP activation and YAP–TEAD-regulated 
gene transcription to promote CIP. Right: A cell depleted of p190A and p190B. 
In this cell, LATS is inactive, which combined with potent mechanotransduc-
tion signaling leads to YAP activation, transcription of YAP–TEAD-regulated 
genes, and escape from CIP, resulting in cell multilayering at high cell density. 
Importantly, inhibition of LATS signaling as well as Rho–ROCK activation is 
required to reach a threshold sufficient to trigger escape from CIP. The relative 
importance of the dual regulation may be context dependent.
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GGA GTT GGA ATT GCT TCC TGT CAC AAT TCC AAC TCC ACA GTT 
ACC TTT TTT GGA ACT CGA GA-3′; and α-catenin shRNA 1, 5′-GAT 
CCC GGC TAA CAG AGA CCT GAT ATT CGG GCC CGG CGG GAG AAT ATC 
AGG TCT CTG TTA GCC TTT TTT GGA ATC GATA-3′.
Lentiviral pZIP vectors encoding shRNAs targeting human 
p190A or p190B message and conferring resistance to neomycin 
were purchased from transOMIC Technologies (TRHS1000-35 
[ARH GAP35/p190A] and TRHS1000-394 [ARH GAP5/p190B]). 
The sequences were as follows: human p190A shRNA 1, 5′-TGC 
TGT TGA CAG TGA GCG CCC TAA TCT AGA TGA AAT AGA ATA GTG 
AAG CCA CAG ATG TAT TCT ATT TCA TCT AGA TTA GGT TGC CTA CTG 
CCT CGGA-3′; shRNA 2, 5′-TGC TGT TGA CAG TGA GCG ACA GGA TTC 
AGA AGA AGA TAT ATA GTG AAG CCA CAG ATG TAT ATA TCT TCT TCT 
GAA TCC TGC TGC CTA CTG CCT CGGA-3′; shRNA 3, 5′-TGC TGT TGA 
CAG TGA GCG CCC TGT CCA TTT TGA AAT TAC ATA GTG AAG CCA CAG 
ATG TAT GTA ATT TCA AAA TGG ACA GGA TGC CTA CTG CCT CGGA-3′; 
and shRNA 4, 5′-TGC TGT TGA CAG TGA GCG CAA GTA GGG AAC AGC 
TAA CTG ATA GTG AAG CCA CAG ATG TAT CAG TTA GCT GTT CCC TAC 
TTA TGC CTA CTG CCT CGGA-3′; human p190B shRNA 1, 5′-TGC 
TGT TGA CAG TGA GCG CCA GCA GAA AAA CTA ATG TAC ATA GTG 
AAG CCA CAG ATG TAT GTA CAT TAG TTT TTC TGC TGA TGC CTA CTG 
CCT CGGA-3′; and shRNA 2, 5′-TGC TGT TGA CAG TGA GCG CAC ATA 
TAG AAC AAC TTA AAC ATA GTG AAG CCA CAG ATG TAT GTT TAA GTT 
GTT CTA TAT GTT TGC CTA CTG CCT CGGA-3′.
Expression constructs encoding rat WT p190A, 
p190A(R1284K), or p190A(ΔGAP) comprising amino acids 
1–1,228, each resistant to knockdown by p190A shRNA 1, were 
generated in pWZL-neo that had been modified to encode a dou-
ble Myc tag on the N terminus. Expression constructs encoding 
YAP5SA or YAP5SA+S94A in pInducer20 were a gift from F.D. 
Camargo (Boston Children's Hospital, Boston, MA) and have 
been described previously (Mori et al., 2014). Expression con-
structs encoding EGFP-RhoA(F30L) or EGFP only under con-
trol of TetR were generated by PCR and cloned into pQCT XN, a 
derivative of pQCX IN that contains the tetO element upstream 
of the CMV promoter.
Table 1. Antibodies used
Antigen Species Company Catalog no. (or clone)
β-Catenin Mouse monoclonal BD 610153
BrdU Mouse monoclonal EMD Millipore/Sigma-Aldrich 05-633
Cyclin A Rabbit polyclonal Santa Cruz Biotechnology, Inc. sc-751
DOCK4 Rabbit polyclonal Abcam ab85723
E-cadherin Rabbit polyclonal Cell Signaling Technologies 3195
E-cadherin Rat monoclonal EMD Millipore/Sigma-Aldrich MABT26
ERK1 Mouse monoclonal Santa Cruz Biotechnology, Inc. sc-271269
ERK1/2 Rabbit polyclonal Santa Cruz Biotechnology, Inc. sc-94
ESM1 Rabbit polyclonal Abcam ab103590
HA tag Mouse monoclonal Hansen laboratory, Boston Children's Hospital, 
Boston, MA
clone 12CA5
LATS1 Rabbit monoclonal Cell Signaling Technologies 3477S
pLATS1/2 Rabbit monoclonal Cell Signaling Technologies 9157S
Myc tag Mouse monoclonal Cell Signaling Technologies 2276
p190A Mouse monoclonal BD 610150
p190A Rabbit polyclonal Bethyl Laboratories A304-549A
p190B Mouse monoclonal BD 611613
p190B Rabbit polyclonal Bethyl Laboratories A301-736A
PAI1 Mouse monoclonal Finsen Laboratory, Rigshospitalet, Copenhagen, 
Denmark
N/A
PARP Mouse monoclonal BD 611039
Rac1 Mouse monoclonal BD 610651
RhoA Mouse monoclonal Santa Cruz Biotechnology, Inc. sc-418
Rnd3 Mouse monoclonal EMD Millipore/Sigma-Aldrich 05-723
Scrib Rabbit polyclonal Santa Cruz Biotechnology, Inc. sc-28737
YAP1 Mouse monoclonal Santa Cruz Biotechnology, Inc. sc-101199
YAP1 Rabbit polyclonal Novus Biologicals NB110-58358
ZO-1 Mouse monoclonal Invitrogen 33-9100
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Inducible RNA interference and gene expression
To permit inducible knockdown of p190A and/or p190B expres-
sion, TR-T10 cells were transduced with retrovirus encoding 
p190A shRNA or p190B shRNA, and the cells were then selected 
with hygromycin (p190A shRNA) or puromycin (p190B shRNA). 
To generate TR-T10 cells with combined knockdown of p190A 
and p190B, p190B-kd cells were transduced with retrovirus 
encoding p190A shRNA, and cells were selected with hygromy-
cin. To induce knockdown of gene expression, cells were plated 
at low density (4 × 103 cells per cm2) and cultured for 3 d in the 
presence of 4 µg/ml doxycycline. Cells were then harvested and 
replated at low (4 × 103 cells per cm2) or high (2 × 105 cells per cm2) 
density and cultured for another 3–5 d before experimentation.
TR-T10 or p190A+B-kd cells with doxycycline-inducible 
expression of YAP5SA or YAP5SA+S94A were generated by 
lentiviral transduction and selected with G418. In cells with 
p190A+B-kd, expression of YAP5SA or YAP5SA+S94A is linked 
to knockdown of p190A and p190B as both are under control 
of the TetR. TR-T10 cells with inducible expression of EGFP or 
EGFP-RhoA(F30L) were generated by retroviral transduction 
and selected with G418. Gene expression was induced accord-
ing to the same protocol as described above for knocking down 
p190A and p190B expression. Plasmid encoding HA-tagged 
murine kinase-dead LATS2(K655R) in pcDNA3-HA generated 
by Zhao et al. (2007) was obtained from Addgene (plasmid 
33100). The mammalian expression cassette was amplified by 
PCR and inserted into pHAGE-CMV-IZsGreen, thus permit-
ting lentiviral transduction of TR-T10 cells with or without 
inducible p190A and p190B knockdown. High-level-express-
ing cells were selected by FACS and used for experimentation. 
HEC-1-A cells with constitutive knockdown of p190A or p190B 
were generated by lentiviral transduction and selected in 
G418-containing medium.
RBD and CRIB assays
RBD and CRIB pulldown assays to detect activated RhoA and 
Rac1, respectively, were performed essentially as previously 
described (Hansen et al., 2000) except that RBD and CRIB beads 
were purchased from Cytoskeleton. In brief, control and p190A- 
and/or p190B-depleted cells with or without treatment with 
Tat-Myc-C3 toxin were lysed in modified gold lysis buffer (1% 
Triton X-100, 20 mM Tris, pH 8.0, 500 mM NaCl, 10 mM MgCl2, 
and 15% glycerol) containing protease inhibitors. Cell lysates 
were cleared by centrifugation for 2 min at 12,000 rpm at 4°C 
in a TOMY MX-301 centrifuge. An aliquot of 100 µl lysate was 
removed and mixed with 2× Laemmli sample buffer for detec-
tion of total Rho/Rac. Next, lysates were transferred to tubes 
containing 20-µl aliquots of RBD or CRIB beads and tumbled end 
over end at for 20 min at 4°C. The RBD/CRIB beads were then 
rinsed twice with modified gold lysis buffer with all remaining 
liquid removed using a Hamilton syringe. The beads were mixed 
with 30 µl of 2× Laemmli sample buffer and heated to 95°C for 
3 min. Finally, samples were electrophoresed on SDS-PAGE gels, 
and active Rho and Rac were detected by Western blotting. Ali-
quots of 1% of total cell lysates were run in parallel to determine 
total Rho and Rac levels.
Confocal fluorescence microscopy
Samples for immunostaining of MDCK cells cultured on perme-
able supports were processed essentially as detailed previously 
(Hansen et al., 2000). Samples were rinsed once with PBS and 
fixed in 3.7% formalin containing 10% methanol for 10 min at RT. 
After rinsing three times with PBS, samples were incubated for 
30 min at RT with blocking buffer (10% normal goat serum, 0.2% 
fish skin gelatin, and 0.1% Triton X-100 in PBS). Next, samples 
were incubated with primary antibodies for 2  h at RT, rinsed 
extensively with PBS containing 0.1% Triton X-100 for 30 min, 
and then incubated with secondary antibodies for 60 min at RT. 
After further extensive rinsing for 30 min, samples were stained 
for 15 min at RT with DRAQ5 to detect nuclei and when relevant, 
fluorescent phalloidin to visualize polymerized actin. After three 
additional brief rinses, samples were mounted with FluorSave 
(EMD Millipore). For MDCK cells cultured in Matrigel, incuba-
tion with primary antibody was performed at 4°C overnight, and 
incubation with secondary antibody for 2 h at RT, but otherwise 
the process was as described for cells grown on permeable sup-
ports. Imaging was performed using line-scanning and spin-
ning-disk confocal microscopes.
TUN EL assay
TUN EL analysis was performed to detect apoptosis in cells shed 
from MDCK cell monolayers. To this end, medium from cell cul-
tures was harvested, and cells were pelleted on slides using a 
Cytospin apparatus. The slides were then immersed in 2% for-
malin for 30 min and rinsed two times with PBS and once with 
distilled water. Cells were permeabilized with ice-cold 70% (vol/
vol) ethanol for 30 min on ice and processed for TUN EL staining 
according to the manufacturer's instructions (In situ Cell Death 
Detection kit; Roche). Finally, nuclei were labeled with DAPI and 
imaged by fluorescence microscopy.
BrdU incorporation
For determining proliferation, cells cultured in 24-well format 
were incubated with BrdU at a final concentration of 10 µM for 
3 h at 37°C. Cells were fixed with 3.7% formalin for 20 min at RT, 
incubated with 1 N HCl for 1 h, and neutralized by addition of an 
equal volume of 0.1 M Na2B4O7. Samples were then processed to 
detect BrdU incorporation by immunofluorescence microscopy as 
described above, except that nuclei were stained with DAPI to per-
mit visualization by conventional immunofluorescence micros-
copy. Next, quantification of BrdU incorporation was performed 
by determining the ratio of BrdU-positive nuclei to total number 
of nuclei essentially as previously described (Hansen et al., 2000).
Aggregation assay
MDCK cells with and without knockdown of p190A and/or p190B 
were harvested by trypsinization, and 2 × 106 cells per condition 
were plated into each well of a 24-well ultralow adhesion cluster 
plate (Corning). After culture for 8 h in suspension, cell clusters 
were triturated 10 times through a 200-µl pipette tip. As negative 
control, we used cells depleted of α-catenin described previously 
(Frank et al., 2012). Quantification of cell aggregation was per-
formed by determining the ratio of area of cells in aggregates 
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to individual cells using ImageJ (National Institutes of Health), 
essentially as detailed by others (Qin et al., 2005).
Real-time qPCR analyses
For real-time qPCR, total RNA was extracted from cell pel-
lets using RNeasy Mini and QIAshredder kits (both QIA GEN) 
according to the manufacturer’s instructions. cDNA was syn-
thetized using iScript Reagents (Bio-Rad Laboratories). Quan-
titative RT-PCR was performed with the One Step plus Sequence 
Detection System using Fast SYBR green master mix reagent 
(Applied Biosystems Ltd.). Gene expression levels were nor-
malized to the mean of at least two housekeeping genes. qPCR 
primers for canine and human genes are listed in Tables 2 and 
3, respectively.
Genome-wide mRNA expression profiling
Total RNA was isolated from 106 MDCK cells using RNeasy 
kit (QIA GEN). RNA integrity was analyzed on a 2100 Bioana-
lyzer using the Agilent RNA 6000 Nano kit (Agilent Technol-
ogies). Only samples with an RNA integrity number >9.5 was 
used for further analysis. cDNAs and libraries were prepared 
using 1 µg total RNA and the TruSeq mRNA sample preparation 
kit according to the manufacturer’s instructions (Illumina). 
Library quality was analyzed on a 2100 Bioanalyzer using the 
Agilent DNA 1000 kit (Agilent Technologies). Library samples 
were quantified using the Qubit dsDNA BR assay kit (Invitro-
gen) and diluted to 10 nM before single-read sequencing on an 
Illumina HiSeq 2000 sequencing platform performed at the 
National High-throughput DNA Sequencing Centre at the Uni-
versity of Copenhagen.
For read mapping and data analysis, reads were aligned in 
single-end mode to canine genome (canFam3; http:// www 
.ensembl .org/ Canis _familiaris/ ) using STAR (version 2.3.1n) 
aligner using default settings (Dobin et al., 2013). Mapped data 
were converted in gene level counts using HTseq-count 0.6.0 
and the ENS EMBL annotation (canFam3.1). Differential expres-
sion was evaluated using DESeq2 Bioconductor package 1.4.5 
(Love et al., 2014).
To identify genes associated with loss of CIP in p190A+B-kd 
cells, we first determined differential gene expression between 
p190A+B-kd and control cells using a threshold of |log2(fold 
Table 2. qPCR primers for canine genes
Gene Forward sequence (5′–3′) Reverse sequence (5′–3′)
ACTB AGA TCT GGC ACC ACA CCT 
TCTA
CAT GAT CTG GGT CAT CTT 
CTCA
ANK RD1 GGC TGA ACC GTT ACA AGA 
TGAT
TGG TTC CAT TCT GCC AGT 
GTAG
CYR61 CAA CGA GGA CTG CAG CAA 
AATG
CCA TTC TGG TAG ATT CGG 
GAGT
DOCK4 CCC AAA TCT CTC TGC ACC 
TGAG
ATC CGA CAT GTT CTT GGC 
TTCT
DUSP2 GCC CTG TGG AGA TCT TAC 
CCTA
TAG CGG AAA AGG CCC TCA 
AAG
ESM1 ACC GGC AAG TGT CTG AAA 
TTTC
TTC TCT CAC AGC ATT GCC 
ATCT
HPRT CTT TGC TGA CCT GCT GGA 
TTAT
TTT ATG TCC CCT GTT GAC 
TGGT
PAI1 TGA CCG ACA TGT TTA GGC 
CAAA
TGT GCC ACT CTC ATT CAC 
TTCA
PDG FB CTC GAT CCG CTC CTT TGA TGA ATC GGG TCA AAT TCA GGT 
CCAA
RND3 GCC AGT TTT GAG ATC GAC 
ACAC
CAA ATC AGC ACA GCA TCC 
GAAT
RPS18 TGA GAA GTT CCA GCA CAT 
TTTG
ATC GAT GTC TGC TTT CCT 
CAAT
SEMA7A GAC CTT CCA CGT GCT TTA 
CCTA
CAT GAT GTT GAA GAC CAG 
GCTG
SLIT2 ACA TTG CCG TGG AGC TGT ATC AGG GCA AGT AGT TCC ACA 
ATGT
TGFB2 AGT TCA GAC ACT CAG CAC AGT TGG GTG TTT TGC CGA TGT 
AGTA
VEG FC TCA GTG CAA GAA CAG AAG 
AGA CT
CCA AAC TCC TTC CCC ACA 
TCTA
Table 3. qPCR primers for human genes
Gene Forward sequence (5′–3′) Reverse sequence (5′–3′)
AMO TL2 AGC TTC AAT GAG GGT CTG 
CTC
CTG CTG AAG GAC CTT GAT 
CACT
ANK RD1 TGA TTA TGT ATG GCG CGG 
ATCT
GCG AGA GGT CTT GTA GGA 
GTTC
CTGF GAA GCT GAC CTG GAA GAG 
AACA
CGT CGG TAC ATA CTC CAC 
AGAA
CYR61 CAT TCC TCT GTG TCC CCA 
AGAA
TAC TAT CCT CGT CAC AGA 
CCCA
DOCK4 ATG AGA CCA TCT TCC AGG 
CAGA
AGC TTT TGA TGT TGT CCG 
GAAC
DUSP2 TTC CGC TAC AAG AGT ATC 
CCTG
TTC ACC CAG TCA ATG AAG 
CCTA
ESM1 GCA TGA CAT GGC ATC TGG 
AGA
CTC AGA AAT CAC AGC CGG 
GATC
HPRT AGC CAG ACT TTG TTG GAT 
TTG
TTT ACT GGC GAT GTC AAT 
AGG
PAI1 TCT CTG CCC TCA CCA ACA 
TTC
CGG TCA TTC CCA GGT TCT 
CTAG
PDG FB TCC CGA GGA GCT TTA TGA 
GATG
GGG TCA TGT TCA GGT CCA 
ACTC
SLIT2 CTG TGT GGG GAA TGA CAG 
TTTC
AGA GTA TCA AAT GCC CCT 
GGTG
VEG FC ACC AAA CAA GGA GCT GGA 
TGAA
ACA CTG GCA TGA GTT TCT 
GTCT
RND3 GGC CAG TTT TGA AAT CGA 
CACA
CAA ATC AGC ACA GCA TCC 
GAAT
RPS18 TTC GGA ACT GAG GCC ATG AT TTT CGC TCT GGT CCG TCT TG
SEMA7A AGA CGC CAT TGT TCC ACT 
CTAA
TGC CCC TGT CTG TAG TTA 
GGTA
TGFB2 CCC CAC ATC TCC TGC TAA 
TGTT
AAG TGG ACG TAG GCA GCA 
ATTA
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change)| ≥1 and adjusted P value ≤0.05. Next, we determined 
differential gene expression between p190A+B-kd and p190A-kd 
as well as p190A+B-kd and p190B-kd cells using a thresh-
old of |log2(fold change)| ≥0.5 and adjusted P value ≤0.05 for 
both analyses. Genes filtered by these thresholds are listed in 
Tables S1 and S2.
Determinations of allelic fraction profile of ARH GAP35 
somatic mutations
We used a compiled patient-derived PanCancer mutation dataset 
(Lawrence et al., 2014) to examine loss-of-function mutations in 
ARH GAP35. A somatic mutation causing protein changes (non-
sense/frameshift indel/missense) and allele fraction >0.5 would 
indicate a complete loss of function of the two normal alleles.
Statistical analyses
Unpaired two-tailed Student t tests were performed as previ-
ously detailed (Hansen et al., 1992).
Online supplemental material
Fig. S1 shows phase images of p190A- and/or p190B-depleted 
MDCK cells by phase microscopy, by TUN EL staining of cells 
detached from cultures grown on permeable supports with or 
without knockdown of p190A and/or p190B as well as cyclin A 
cell proliferation data for adherent cells. Fig. S2 shows a z stack 
of confocal microscopy images of p190A+B-kd cells along with 
accompanying x–y and z images. Fig. S3 illustrates effects of 
p190A and/or p190B knockdown on adherens and tight junctions. 
Fig. S4 demonstrates effects of C3 toxin and ROCK inhibitor on 
p190A- and/or p190B-depleted cells. Fig. S5 shows images of YAP, 
E-cadherin, and β-catenin staining control, p190A-kd, p190B-kd, 
and p190A+B-kd MCDK cell spheroids cultured in Matrigel. Table 
S1 shows mRNA-seq analysis of up-regulated dense cultures. 
Table S2 shows mRNA-seq analysis of down-regulated dense cul-
tures. Table S3 shows mRNA-seq analysis of up-regulated sparse 
cultures. Table S4 shows mRNA-seq analysis of down-regulated 
sparse cultures.
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